Luke Littler’s rise has changed more than darts scorelines. His newly signed long-term deal with Target Darts highlights how ...

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today highlighted pipeline ...

StoneX Group Inc. is rated a Buy due to inevitable market volatility and the accretive acquisition. Learn more about SNEX ...

An analyst from JP Morgan persists with their Overweight rating on RTX, maintaining a target price of $200. Reflecting concerns, an analyst from UBS lowers its rating to Neutral with a new price ...

In 2025, Tevogen advanced its proprietary ExacTcell™ platform, expanded its cytotoxic T lymphocyte (CTL) pipeline across ...

Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 ...

A long drive, heavy traffic and bad weather conditions over the mountains are among the difficulties Yakima Valley travelers ...

DRAM super cycle, High-NA EUV ramp, margin gains, and valuation upside. It expects significantly lower China demand in 2026.

Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. "2025 was ...

Sritex ex-workers affected by the mass layoffs are no longer of a productive age and highly dependent on severance pay and ...

FY 2025 Preliminary Unaudited Total Revenue of Approximately $510--511 Million Meets or Exceeds Prior Guidance Previously Provided FY 2025 Adjusted EBITDA (1) and Adjusted Net Income (2) Guidance ...

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...